RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that Frank J. Malinoski, M.D., Ph.D., has joined the company as Chief Medical Officer.
